Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology

ASCO summarizes issues and recommendations related to the 340B Drug Pricing Program for policymakers to consider from the perspective of professionals dedicated to the prevention, diagnosis, and treatment of cancer.